Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > Does this make the success of PPP001 very low?
View:
Post by TheGreenExpress on Nov 23, 2018 3:45pm

Does this make the success of PPP001 very low?

Found this article that i think relates to our PPP001. It's kinda got me on the fence as to the success of us actualy getting a DIN for a smokable drug. Let me know what you think.

FDA Commissioner Scott Gottlieb “Using a lung as a drug delivery vehicle isn’t optimal,” “That’s not to say that we wouldn’t evaluate it if it came in; it just wouldn’t be an optimal way to deliver an active ingredient,” 
https://www.bloomberg.com/news/articles/2018-05-07/don-t-expect-joints-if-the-fda-ever-approves-medical-marijuana
Comment by LeafRider on Nov 23, 2018 4:51pm
This post has been removed in accordance with Community Policy
Comment by moasat1 on Nov 23, 2018 5:25pm
Well said Leafrider. Stupid comment by the FDA and I love your example of asthma medicine. I think some nitrogen for angina is delivered that way as well. 
Comment by TheGreenExpress on Nov 23, 2018 5:28pm
Listen there is know need to get all snappy! It's a discussion board right? As an investor you need to look at both sides "the good and the bad" when doing your DD. At the end of the day the FDA makes the decision as to which drugs get approved correct? In our case it's Health Canada followed by a review from the FDA. I've been a shareholder in this company since 2016 so no ...more  
Comment by Sweeetydi on Nov 23, 2018 5:51pm
We already have orphan drug status for ppp001 granted by the FDA in the USA.  This would lead to believe that with solid evidence, it will be granted FDA approval.  Also, the patient population that TBP is studying is of key importance when considering the mode of ingestion.
Comment by Nevermind21 on Nov 23, 2018 5:58pm
Hi Green, I think what the comissioner is actually saying isn't so bad but I can understand how reading that it may make you question your investment and the FDA's stance on allowing this. I mean, it's common sense to do such a thing - it would be blind to not seeing as you are invested in a bio pharma trial. The commissioner even says he is still open to the possiblity so that is ...more  
Comment by moasat1 on Nov 24, 2018 6:10am
It’s funny how people read things. Your point about asking tough questions is valid and what I believe in. However, i do believe that the comments made by the FDA (not you) are stupid considering there are many other drugs that are taken by inhalation. Does that mean those drugs should be reviewed and perhaps taken off the shelf? I don’t believe so. If Tetras products work, then they will be ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities